Klain Michele, Ricard Marcel, Leboulleux Sophie, Baudin Eric, Schlumberger Martin
Department of Nuclear Medicine and Commissariat à l'Energie Atomique LRC 29V, Institut Gustave Roussy, 94805 Villejuif Cedex, France.
Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S479-85. doi: 10.1007/s00259-002-0810-9. Epub 2002 May 9.
Radioiodine ((131)I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.
放射性碘(¹³¹I)治疗用于乳头状和滤泡状甲状腺癌患者,以消融甲状腺残余组织并治疗持续性或复发性疾病。应选择性地使用,即仅用于那些可能预期有临床获益的患者。